Lack of Benefit of Fluvoxamine for COVID-19
Author:
Affiliation:
1. Division of Infectious Diseases, Houston Methodist Hospital, Houston, Texas
2. Department of Pharmacy Practice, Temple University, Philadelphia, Pennsylvania
Publisher
American Medical Association (AMA)
Subject
General Medicine
Link
https://jamanetwork.com/journals/jama/articlepdf/2800449/jama_bhimraj_2023_ed_220108_1674242729.01249.pdf
Reference8 articles.
1. Coronavirus disease 2019 treatment: a review of early and emerging options.;McCreary;Open Forum Infect Dis,2020
2. Mechanisms of action of fluvoxamine for COVID-19: a historical review.;Hashimoto;Mol Psychiatry,2022
3. Effect of fluvoxamine vs placebo on time to sustained recovery in outpatients with mild to moderate COVID-19: a randomized clinical trial.;McCarthy;JAMA
4. Randomized trial of metformin, ivermectin, and fluvoxamine for Covid-19.;Bramante;N Engl J Med,2022
5. Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial.;Reis;Lancet Glob Health,2022
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Recent progress on the application of MOFs and their derivatives in adsorbing emerging contaminants;Separation and Purification Technology;2024-12
2. Adverse events related to drug–drug interactions in COVID-19 patients. A persistent concern in the post-pandemic era: a systematic review;Expert Opinion on Drug Metabolism & Toxicology;2024-04-02
3. Unravelling Insights into the Evolution and Management of SARS-CoV-2;BioMedInformatics;2024-02-03
4. Evaluating fluvoxamine for the outpatient treatment of COVID‐19: A systematic review and meta‐analysis;Reviews in Medical Virology;2023-12-26
5. Fluvoxamine vs Placebo and Time to Recovery in Outpatients With Mild to Moderate COVID-19;JAMA;2023-05-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3